| Identification | |
| Name: | Piperidine,1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-, hydrochloride (1:1) |
| Synonyms: | Nitossil;Novotusil;Seki;p-Chlorobenzhydryl 2-(1-piperidyl)ethyl ether hydrochloride;Piperidine,1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-, hydrochloride (9CI);Piperidine,1-[2-[(p-chloro-a-phenylbenzyl)oxy]ethyl]-,hydrochloride (6CI,8CI);HT 11;Hustazol; |
| CAS: | 14984-68-0 |
| EINECS: | 239-067-8 |
| Molecular Formula: | C20H24ClNO.HCl |
| Molecular Weight: | 366.33 |
| InChI: | InChI=1/C20H24ClNO.ClH/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22;/h1,3-4,7-12,20H,2,5-6,13-16H2;1H |
| Molecular Structure: |  |
| Properties | |
| Density: | g/cm3 |
| Specification: |
Cloperastine hydrochloride , its cas register number is 14984-68-0. It also can be called 1-{2-[(4-chlorophenyl)(phenyl)methoxy]ethyl}piperidine hydrochloride (1:1) ; 2-Piperidinoethyl p-chlorobenzhydryl ether hydrochloride ; Cloperastine HCl ; Hustazol . Its classification code is Drug / Therapeutic Agent. |
| Safety Data | |
| Hazard Symbols |
Xn:Harmful
|
 |
|
